Target identification of biologically active small molecules via in situ methods

- Drug discovery is time-consuming and expensive in part due to unexpected side-effects.
- Identification of cellular targets of drug candidates is important to address this issue.
- In situ proteome profiling using small molecule probes can identify potential cellular targets of bioactive compounds.
- Both non-covalent and covalent drugs are applicable.